ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,091Medicare Part D Prescriptions Filled, Including Refills
$769K Total Retail Price of All Prescriptions
429 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
MIRTAZAPINE 652 569
VENLAFAXINE HCL ER 480 421
DONEPEZIL HCL 412 385
SERTRALINE HCL 365 353
QUETIAPINE FUMARATE 351 311
NAMENDA 340 326
CITALOPRAM HBR 315 261
TRAZODONE HCL 188 160
CYMBALTA 175 152
GABAPENTIN 169 145
SEROQUEL XR 155 140
LAMOTRIGINE 154 98
HYDROCODONE-ACETAMINOPHEN 151 101 S3
OLANZAPINE 150 133
SEROQUEL 144 132
RISPERIDONE 144 118
ABILIFY 124 84
FLUOXETINE HCL 114 94
CLONAZEPAM 111 97
BUPROPION HCL SR 108 75
CLOZAPINE 104 65
ESCITALOPRAM OXALATE 100 99
VENLAFAXINE HCL 93 93
TOPIRAMATE 92 62
PRISTIQ ER 84 63
EXELON 79 79
LORAZEPAM 74 71
ZOLPIDEM TARTRATE 68 52
ARICEPT 62 50
LITHIUM CARBONATE 62 50
CARBIDOPA-LEVODOPA 61 61
TRANYLCYPROMINE SULFATE 53 53 10
DIVALPROEX SODIUM 51 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.